top of page

Ongoing Fundings

Grant Type
Project Title
Amount
Start Date
Completion Date
Principal Investigator
GRF (17121520)
Androgen regulates white adipose tissue remodelling via suppression of PRDM16
1,145,727.00
31/12/2020
30/12/2023
Dr. Xiaoyan HUI
GRF (17121819)
The Single Transmembrane Protein β-klotho as a Novel Regulator of Insulin Secretion in Pancreatic β-cells
1,684,895.00
31/12/2019
30/12/2022
Prof. Aimin XU
GRF (17117320)
The mechano-sensitive ion channel Piezo1 balances the conversion of mesenchymal stem cells to osteoblasts and bone marrow adipocytes
1,195,542.00
31/12/2020
30/12/2023
Prof. Aimin XU
E-HKU703/20
Targeting Gut Microbiota for Non-alcoholic Fatty Liver Disease
1,691,843.00
30/09/2020
30/08/2020
Prof. Aimin XU
Guangdong-Hong Kong Technology Cooperation Funding Scheme
Development and Preclinical Evaluation of a A-FABP Neutralizing Monoclonal Antibody for Ischemic Stroke Treatment
1,327,458.00
31/08/2019
30/08/2021
Dr. Ruby Lai Chong HOO
HMRF (17123718)
Deletion of Telomere-Rap1 increases the susceptibility to myocardial ischemia/reperfusion injury via p53-PGC1α signaling during aging
868,463.00
31/12/2018
30/12/2021
Dr. Zhengyuan XIA
HMRF (81803769)
Hydrogen sulfide-responsive small-molecule nanoparticles as drug delivery carriers for cancer therapy and diagnosis
263,760.00
31/12/2018
30/12/2021
Dr. Weiping WANG
GRF (06173456)
Development of ultrasound-responsive polymeric nanoreactors for retinoblastoma therapy
1,499,628.00
31/07/2019
30/07/2022
Dr. Weiping WANG
HMRF (06172266)
Exploring the role of microRNA in sight-threatening diabetic retinopathy in Chinese patients with type 2 diabetes
1,499,956.00
31/07/2019
30/07/2022
Dr. Yu Yan CHEUNG
HMRF (06172636)
Targeting G protein-coupled receptor 110 for the treatment of obesity and non-alcoholic fatty liver disease
1,399,248.00
29/04/2019
29/04/2022
Dr. Zhe HUANG
GRF (17105318)
Neutrophil serine proteases as the endogenous suppressors of white adipose tissue browning and adaptive thermogenesis
775,656.00
31/12/2018
30/12/2021
Dr. Ruby Lai Chong HOO
HMRF (06172646)
Mitochondrial protein coiled-coil-helix-coiled-coil-helix domain 10 (Chchd10) as a novel factor for the treatment of obesity and its related diseases
982,396.00
31/05/2019
30/05/2021
Dr. Ruby Lai Chong HOO

L8, Li Ka Shing Faculty of Medicine, 21 Sassoon Road, Pokfulam, Hong Kong

(852) 3917 9766

Copyright ©2020 State Key Laboratory of Pharmaceutical Biotechnology.  All Rights Reserved.

bottom of page